Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | GUSB | P08236 | 1/20 | 0.37 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5767491 | 0.90 | CA1 (0.47) | CHRM5CHRM1ALDH1A1LMNAKMT2A | |
| SCHEMBL5911606 | 0.88 | CHRM5 (0.43) | CHRM5CHRM1ALDH1A1LMNAALOX12 | |
| SCHEMBL5911334 | 0.88 | MMP2 (0.47) | ALDH1A1LMNAALOX12HTTKMT2A | |
| SCHEMBL5766980 | 0.88 | ESR1 (0.44) | CHRM5CHRM1ALDH1A1LMNACA1 | |
| SCHEMBL5911255 | 0.87 | NPC1 (0.49) | CHRM5CHRM1ALDH1A1HTTKMT2A | |
| SCHEMBL5911423 | 0.86 | MAOB (0.39) | CHRM5CHRM1ALDH1A1LMNAALOX12 | |
| SCHEMBL5911437 | 0.86 | CNR2 (0.41) | CHRM5CHRM1ALDH1A1CA1CA2 | |
| SCHEMBL5911151 | 0.84 | CHRM5 (0.46) | CHRM5CHRM1ALDH1A1CA1CA2 | |
| SCHEMBL5911402 | 0.83 | CA1 (0.40) | CHRM5CHRM1ALDH1A1LMNAALOX12 | |
| SCHEMBL5911451 | 0.81 | CHRM5 (0.38) | CHRM5CHRM1ALDH1A1LMNAALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060116390-A1 | Hepatitis c virus inhibitors | LG LIFE SCIENCES LTD. (KR) | 2006-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060116390-A1 | Hepatitis c virus inhibitors | HAVCR2, LIPC, FABP1 | CHRM5 4780/4885CHRM1 4676/4885ALDH1A1 1058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.